PaxMedica (PXMD) Competitors $0.03 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends PXMD vs. AKAN, APVO, WINT, ADTX, RNAZ, REVB, SXTP, BON, GLMD, and PBLAShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Akanda (AKAN), Aptevo Therapeutics (APVO), Windtree Therapeutics (WINT), Aditxt (ADTX), TransCode Therapeutics (RNAZ), Revelation Biosciences (REVB), 60 Degrees Pharmaceuticals (SXTP), Bon Natural Life (BON), Galmed Pharmaceuticals (GLMD), and Panbela Therapeutics (PBLA). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Akanda Aptevo Therapeutics Windtree Therapeutics Aditxt TransCode Therapeutics Revelation Biosciences 60 Degrees Pharmaceuticals Bon Natural Life Galmed Pharmaceuticals Panbela Therapeutics PaxMedica (NASDAQ:PXMD) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Which has more volatility & risk, PXMD or AKAN? PaxMedica has a beta of -0.4, suggesting that its share price is 140% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Do institutionals & insiders hold more shares of PXMD or AKAN? 4.9% of PaxMedica shares are held by institutional investors. Comparatively, 1.0% of Akanda shares are held by institutional investors. 1.0% of PaxMedica shares are held by company insiders. Comparatively, 20.4% of Akanda shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to PXMD or AKAN? In the previous week, PaxMedica's average media sentiment score of 0.00 equaled Akanda'saverage media sentiment score. Company Overall Sentiment PaxMedica Neutral Akanda Neutral Does the MarketBeat Community prefer PXMD or AKAN? PaxMedica received 1 more outperform votes than Akanda when rated by MarketBeat users. CompanyUnderperformOutperformPaxMedicaOutperform Votes1100.00% Underperform VotesNo VotesAkandaN/AN/A Which has better earnings & valuation, PXMD or AKAN? PaxMedica has higher earnings, but lower revenue than Akanda. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPaxMedicaN/AN/A-$18.29MN/AN/AAkanda$2.16M1.08-$32.28MN/AN/A Is PXMD or AKAN more profitable? Akanda's return on equity of 0.00% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets PaxMedicaN/A -3,167.89% -560.35% Akanda N/A N/A N/A SummaryAkanda beats PaxMedica on 5 of the 8 factors compared between the two stocks. Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$351,000.00$6.58B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0188.8317.53Price / SalesN/A335.611,282.2680.28Price / CashN/A22.6336.6032.90Price / Book0.075.084.964.69Net Income-$18.29M$154.90M$117.89M$224.57M7 Day PerformanceN/A2.59%2.75%3.33%1 Month PerformanceN/A1.52%3.63%5.33%1 Year PerformanceN/A5.49%27.27%22.97% PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/A$0.03flatN/A-94.5%$351,000.00N/A0.002AKANAkandaN/A$1.63+4.5%N/A-95.2%$2.33M$2.51M0.00110Positive NewsAPVOAptevo Therapeutics2.6225 of 5 stars$4.55-5.0%$10,952.00+240,603.3%-100.0%$2.33M$3.11M0.0050Positive NewsWINTWindtree Therapeutics2.1563 of 5 stars$0.25-0.9%$7.00+2,667.9%-97.6%$2.27MN/A-0.0230Gap DownADTXAditxt0.1944 of 5 stars$0.16-8.2%N/A-99.9%$2.22M$212,107.000.0047News CoverageGap UpRNAZTransCode Therapeutics1.8165 of 5 stars$3.18-3.0%$20.00+528.9%-99.6%$2.21MN/A0.009Positive NewsHigh Trading VolumeREVBRevelation Biosciences0.6373 of 5 stars$0.50-5.5%N/A-96.8%$2.15MN/A-0.0310News CoverageGap DownSXTP60 Degrees Pharmaceuticals0.835 of 5 stars$0.92-12.4%N/A+32.3%$2.11M$502,409.00-0.093Analyst ForecastGap DownBONBon Natural LifeN/A$1.67+0.0%N/A-71.6%$1.96M$25.56M0.00100Positive NewsGLMDGalmed Pharmaceuticals1.87 of 5 stars$2.88-0.7%N/A-28.3%$1.86MN/A-0.1720Positive NewsPBLAPanbela TherapeuticsN/A$0.37-1.4%N/A-94.6%$1.77MN/A-0.016Gap Down Related Companies and Tools Related Companies AKAN Alternatives APVO Alternatives WINT Alternatives ADTX Alternatives RNAZ Alternatives REVB Alternatives SXTP Alternatives BON Alternatives GLMD Alternatives PBLA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PXMD) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
